News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
884,929 Results
Type
Article (88874)
Company Profile (816)
Press Release (795219)
Multimedia
Podcasts (242)
Webinars (35)
Section
Business (233635)
Career Advice (4164)
Deals (40010)
Drug Delivery (180)
Drug Development (91754)
Employer Resources (207)
FDA (18577)
Job Trends (17492)
News (398827)
Policy (40020)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3055)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (42)
Allergies (208)
Alliances (56990)
ALS (242)
Alzheimer's disease (1983)
Antibody-drug conjugate (ADC) (575)
Approvals (18954)
Artificial intelligence (897)
ASCO (345)
Autoimmune disease (373)
Automation (69)
Bankruptcy (409)
Best Places to Work (12635)
BIO (73)
BIOSECURE Act (23)
Biosimilars (250)
Biotechnology (482)
Bladder cancer (214)
Brain cancer (86)
Breast cancer (854)
Cancer (6708)
Cardiovascular disease (566)
Career advice (3600)
Career pathing (52)
CAR-T (391)
CDC (77)
Celiac Disease (3)
Cell therapy (1093)
Cervical cancer (58)
Clinical research (79234)
Collaboration (2424)
Commercialization (1)
Company closure (8)
Compensation (1543)
Complete response letters (107)
COVID-19 (3044)
CRISPR (127)
C-suite (1319)
Cystic fibrosis (168)
Data (8866)
Decentralized trials (3)
Denatured (93)
Depression (199)
Dermatology (99)
Diabetes (717)
Diagnostics (7623)
Digital health (71)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (451)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (327)
Earnings (102517)
Editorial (80)
Employer branding (25)
Employer resources (175)
Events (138884)
Executive appointments (1207)
FDA (22754)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (21)
Frontotemporal dementia (36)
Funding (1998)
Gene editing (276)
Generative AI (91)
Gene therapy (862)
GLP-1 (1293)
Government (5569)
Grass and pollen (8)
Guidances (423)
Healthcare (21270)
Hematology (198)
HIV (99)
Huntington's disease (67)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (360)
Immuno-oncology (116)
Indications (219)
Infectious disease (3452)
Inflammatory bowel disease (245)
Inflation Reduction Act (17)
Influenza (154)
Intellectual property (328)
Interviews (822)
IPO (18009)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (23)
Labor market (125)
Layoffs (693)
Leadership (54)
Legal (10171)
Liver cancer (111)
Longevity (38)
Lung cancer (884)
Lymphoma (484)
Machine learning (70)
Management (67)
Manufacturing (1267)
Marketing (3)
MASH (229)
Medical affairs (1)
Medical device (15297)
Medtech (15474)
Mergers & acquisitions (23325)
Metabolic disorders (1854)
mRNA (275)
Multiple sclerosis (210)
NASH (24)
Neurodegenerative disease (522)
Neuropsychiatric disorders (131)
Neuroscience (3773)
Neurotech (2)
NextGen: Class of 2026 (7717)
Non-profit (5147)
Now hiring (83)
Obesity (883)
Opinion (378)
Ovarian cancer (248)
Pain (288)
Pancreatic cancer (370)
Parkinson's disease (424)
Partnered (41)
Patents (670)
Patient recruitment (793)
Peanut (71)
People (68108)
Pharmaceutical (136)
Pharmacy benefit managers (38)
Phase 1 (24486)
Phase 2 (34427)
Phase 3 (25879)
Pipeline (10068)
Policy (404)
Postmarket research (3560)
Preclinical (10998)
Press Release (72)
Prostate cancer (353)
Psychedelics (73)
Radiopharmaceuticals (376)
Rare diseases (1304)
Real estate (7462)
Recruiting (81)
Regulatory (30547)
Reports (77)
Research institute (2773)
Resumes & cover letters (654)
Rett syndrome (46)
RNA editing (31)
RSV (100)
Schizophrenia (197)
Series A (342)
Series B (250)
Service/supplier (28)
Sickle cell disease (129)
Special edition (32)
Spinal muscular atrophy (191)
Sponsored (55)
Startups (4375)
State (2)
Stomach cancer (21)
Supply chain (149)
Tariffs (104)
The Weekly (146)
Vaccines (1320)
Venture capital (141)
Weight loss (601)
Women's health (146)
Worklife (25)
Date
Today (31)
Last 7 days (491)
Last 30 days (2475)
Last 365 days (33018)
2026 (17293)
2025 (33217)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (102)
Alaska (7)
Arizona (409)
Arkansas (16)
Asia (52380)
Australia (9206)
California (14573)
Canada (4075)
China (1618)
Colorado (625)
Connecticut (648)
Delaware (451)
Europe (120780)
Florida (2177)
Georgia (473)
Hawaii (4)
Idaho (70)
Illinois (1276)
India (107)
Indiana (675)
Iowa (26)
Japan (615)
Kansas (144)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1757)
Massachusetts (10677)
Michigan (427)
Minnesota (813)
Mississippi (7)
Missouri (165)
Montana (37)
Nebraska (31)
Nevada (155)
New Hampshire (92)
New Jersey (3863)
New Mexico (35)
New York (3844)
North Carolina (1955)
North Dakota (11)
Northern California (7254)
Ohio (456)
Oklahoma (27)
Oregon (55)
Pennsylvania (2862)
Puerto Rico (33)
Rhode Island (55)
South America (1669)
South Carolina (89)
South Dakota (2)
Southern California (5727)
Tennessee (235)
Texas (2385)
United States (52157)
Utah (434)
Vermont (2)
Virginia (376)
Washington D.C. (89)
Washington State (1193)
West Virginia (4)
Wisconsin (161)
Wyoming (2)
There are 884,929 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Harbour BioMed Appoints Dr. Lloyd Klickstein as Scientific Advisor for Immunology
June 29, 2026
·
3 min read
Rare diseases
BridgeBio’s achondroplasia pill shows ‘compelling’ growth and body proportionality benefit
BridgeBio Pharma plans to file for approval in the third quarter. If granted, the oral drug could present a “highly differentiated” option over current achondroplasia therapies, according to Jefferies.
June 29, 2026
·
2 min read
·
Tristan Manalac
Ovarian cancer
4 ovarian cancer candidates to watch: GSK, Allarity and more
Recent approvals for Corcept Therapeutics and Merck have injected momentum into the space, where GSK, Allarity Therapeutics, OSE Immunotherapies and others are advancing their own candidates.
June 29, 2026
·
6 min read
·
Brianna Abbott
Press Releases
BridgeBio Announces Publication in the New England Journal of Medicine of Phase 3 PROPEL 3 Trial of Oral Infigratinib in Children Living with Achondroplasia
June 28, 2026
·
11 min read
Press Releases
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
June 28, 2026
·
5 min read
Press Releases
Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease
June 28, 2026
·
11 min read
Press Releases
Thubrikar Aortic Valve partners with MAC’s MEDICAL Group and expands the TAVI-1 CE Mark trial of the Optimum TAVI System™
June 28, 2026
·
3 min read
Press Releases
Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results
June 28, 2026
·
11 min read
Press Releases
Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
June 28, 2026
·
4 min read
Press Releases
SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease
June 28, 2026
·
13 min read
1 of 88,493
Next
